Literature DB >> 19527179

Iron and menopause: does increased iron affect the health of postmenopausal women?

Jinlong Jian1, Edward Pelle, Xi Huang.   

Abstract

Estrogen deficiency has been regarded as the main causative factor in menopausal symptoms and diseases. Here, we show that although estrogen decreases by 90%, a concurrent but inverse change occurs in iron levels during menopausal transition. For example, levels of serum ferritin are increased by two- to threefold from before menopause to after menopause. This observation has led us to hypothesize that, in addition to estrogen deficiency, increased iron as a result of menopause could be a risk factor affecting the health of postmenopausal women. Further studies on iron and menopause are clinically relevant and may provide novel therapeutic treatments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527179      PMCID: PMC2821138          DOI: 10.1089/ars.2009.2576

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  46 in total

Review 1.  Estrogen and the risk of breast cancer.

Authors:  M Clemons; P Goss
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

2.  Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis.

Authors:  Jerome L Sullivan
Journal:  Am Heart J       Date:  2003-02       Impact factor: 4.749

3.  Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial.

Authors:  P Ravn; M Bidstrup; R D Wasnich; J W Davis; M R McClung; A Balske; C Coupland; O Sahota; A Kaur; M Daley; G Cizza
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

4.  Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.

Authors:  E B Gold; B Sternfeld; J L Kelsey; C Brown; C Mouton; N Reame; L Salamone; R Stellato
Journal:  Am J Epidemiol       Date:  2000-09-01       Impact factor: 4.897

5.  Photodegraded nifedipine stimulates uptake and retention of iron in human epidermal keratinocytes.

Authors:  A B Gruen; J Zhou; K A Morton; L M Milstone
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

6.  Bone metabolism and oxidative stress in postmenopausal rats with iron overload.

Authors:  Haruo Isomura; Katsutoshi Fujie; Kouichi Shibata; Nobuo Inoue; Tadashi Iizuka; Gen Takebe; Kazuhiko Takahashi; Jun Nishihira; Hiroshi Izumi; Wataru Sakamoto
Journal:  Toxicology       Date:  2004-04-15       Impact factor: 4.221

7.  Bone morphology, strength and density are compromised in iron-deficient rats and exacerbated by calcium restriction.

Authors:  Denis M Medeiros; Aaron Plattner; Dianne Jennings; Barbara Stoecker
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

8.  Involvement of lipid peroxidation and organic peroxides in UVA-induced matrix metalloproteinase-1 expression.

Authors:  Tobias Polte; Rex M Tyrrell
Journal:  Free Radic Biol Med       Date:  2004-06-15       Impact factor: 7.376

Review 9.  Role of iron in osteoporosis.

Authors:  Eugene D Weinberg
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

10.  Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people.

Authors:  Masaru Nakano; Yoshikazu Kawanishi; Seika Kamohara; Yoshiko Uchida; Mami Shiota; Yuka Inatomi; Toyonori Komori; Katsumi Miyazawa; Kazumi Gondo; Ikuhiro Yamasawa
Journal:  Free Radic Biol Med       Date:  2003-10-01       Impact factor: 7.376

View more
  43 in total

1.  17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site.

Authors:  Qing Yang; Jinlong Jian; Stuart Katz; Steven B Abramson; Xi Huang
Journal:  Endocrinology       Date:  2012-04-25       Impact factor: 4.736

2.  Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.

Authors:  Bin Chen; Guang-Fei Li; Ying Shen; X I Huang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

3.  Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer.

Authors:  Jinlong Jian; Qing Yang; Jisen Dai; Jonathan Eckard; Deborah Axelrod; Debrah Axelrod; Julia Smith; Xi Huang
Journal:  Free Radic Biol Med       Date:  2010-12-28       Impact factor: 7.376

4.  Occupational exposure to metals and risk of meningioma: a multinational case-control study.

Authors:  Siegal Sadetzki; Angela Chetrit; Michelle C Turner; Martie van Tongeren; Geza Benke; Jordi Figuerola; Sarah Fleming; Martine Hours; Laurel Kincl; Daniel Krewski; Dave McLean; Marie-Elise Parent; Lesley Richardson; Brigitte Schlehofer; Klaus Schlaefer; Maria Blettner; Joachim Schüz; Jack Siemiatycki; Elisabeth Cardis
Journal:  J Neurooncol       Date:  2016-09-23       Impact factor: 4.130

5.  Hepatic magnetic resonance imaging with T2* mapping of ovariectomized rats: correlation between iron overload and postmenopausal osteoporosis.

Authors:  Lingshan Chen; Zhengqiu Zhu; Xingui Peng; Yuancheng Wang; Yaling Wang; Min Chen; Qi Wang; Jiyang Jin
Journal:  Eur Radiol       Date:  2014-04-28       Impact factor: 5.315

6.  Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis?

Authors:  Xi Huang; Youjia Xu; Nicola C Partridge
Journal:  Bone       Date:  2013-03-22       Impact factor: 4.398

Review 7.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

8.  The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010).

Authors:  B-J Kim; S H Lee; J-M Koh; G S Kim
Journal:  Osteoporos Int       Date:  2013-04-17       Impact factor: 4.507

9.  Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.

Authors:  Guo-yang Zhao; Dong-hua Di; Bo Wang; Xi Huang; You-jia Xu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

10.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.